Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for Altimmune, Inc. Common stock, par value $0.0001 per share (ALT).
- Disclosed ownership: 10%.
- Date of event: 23 Apr 2026.
Deep Track Capital, LP - 23 Apr 2026 SCHEDULE 13G Report for Altimmune, Inc. Common stock, par value $0.0001 per share (ALT)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- ALT
- Shares outstanding
- 194,366,577 shares
- Disclosed Ownership
- 19,417,221 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 30 Apr 2026, 16:00:10 UTC
- Date of event
- 23 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 10% ownership in Altimmune, Inc. Common stock, par value $0.0001 per share (ALT) on 23 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Apr 2026, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 10% | 19,417,221 | 0 | 19,417,221 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 8.6% | 16,828,258 | 0 | 16,828,258 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 10% | 19,417,221 | 0 | 19,417,221 | /s/ David Kroin | David Kroin | |
| Deep Track Special Opportunities Fund, LP. | 1.3% | 2,588,963 | 0 | 2,588,963 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP |